Evidence map›Paper›PMID 27130330›Full record

ArticleBMC bioinformatics2016

G-DOC Plus - an integrative bioinformatics platform for precision medicine.

Krithika Bhuvaneshwar, Anas Belouali, Varun Singh, Robert M Johnson, Lei Song, Adil Alaoui, Michael A Harris, Robert Clarke, Louis M Weiner, Yuriy Gusev and 1 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. PMBC: a manually curated database for prognostic markers of breast cancer.Database : the journal of biological databases and curation · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. PRISM: A Platform for Imaging in Precision Medicine.JCO clinical cancer informatics · 2020
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Krithika BhuvaneshwarInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Anas BeloualiInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Varun SinghInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Robert M JohnsonInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Lei SongInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Adil AlaouiInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Michael A HarrisInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Robert ClarkeDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Louis M WeinerDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Yuriy GusevInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA.
Subha MadhavanInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA. sm696@georgetown.edu.

Funding

Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Novel Targets in Endocrine ResponsivenessU54CA149147 · NCI · GEORGETOWN UNIVERSITY · PI MADHAVAN, SUBHA · 2010 to 2014
$6.9M
Georgetown University Center of Excellence in Regulatory Science and Innovation (CERSI)U01FD004319 · FDA · GEORGETOWN UNIVERSITY · PI DRETCHEN, KENNETH L, MADHAVAN, SUBHA · 2011 to 2016
$3.8M
CCR NIH HHS HHSN261200800001CFDA HHS U01 FD004319NCATS NIH HHS UL1 TR000101NCATS NIH HHS UL1 TR001409NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

backgroundG-DOC Plus is a data integration and bioinformatics platform that uses cloud computing and other advanced computational tools to handle a variety of biomedical BIG DATA including gene expression arrays, NGS and medical images so that they can be analyzed in the full context of other omics and clinical information.

resultsG-DOC Plus currently holds data from over 10,000 patients selected from private and public resources including Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA) and the recently added datasets from REpository for Molecular BRAin Neoplasia DaTa (REMBRANDT), caArray studies of lung and colon cancer, ImmPort and the 1000 genomes data sets. The system allows researchers to explore clinical-omic data one sample at a time, as a cohort of samples; or at the level of population, providing the user with a comprehensive view of the data. G-DOC Plus tools have been leveraged in cancer and non-cancer studies for hypothesis generation and validation; biomarker discovery and multi-omics analysis, to explore somatic mutations and cancer MRI images; as well as for training and graduate education in bioinformatics, data and computational sciences. Several of these use cases are described in this paper to demonstrate its multifaceted usability.

conclusionG-DOC Plus can be used to support a variety of user groups in multiple domains to enable hypothesis generation for precision medicine research. The long-term vision of G-DOC Plus is to extend this translational bioinformatics platform to stay current with emerging omics technologies and analysis methods to continue supporting novel hypothesis generation, analysis and validation for integrative biomedical research. By integrating several aspects of the disease and exposing various data elements, such as outpatient lab workup, pathology, radiology, current treatments, molecular signatures and expected outcomes over a web interface, G-DOC Plus will continue to strengthen precision medicine research. G-DOC Plus is available at: https://gdoc.georgetown.edu .

Indexed as

Databases, FactualComputational BiologyHumansNeoplasmsOligonucleotide Array Sequence AnalysisPrecision MedicineTranscriptomeBioinformaticsCloud computingGenotype-phenotype integrationNext generation sequencingOutcomes researchPrecision medicineTranslational researchVariant analysis

Identifiers

PMID27130330
PMCPMC4851789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.